Shorter time to distant metastasis and overall survival occurred in stage III rectal cancer lacking MMP2. Furthermore, the authors confirmed that MMP2 inhibitors promoted cell invasion in CRC cell lines in vitro. Here, MMP2 is linked to colorectal carcinoma.